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Abstract
Background: Quinine has been reported to possess anti-spermatogenic activities.
Objectives: This study was carried out to determine the effect of  quinine on ovarian function in Sprague-Dawley rats.
Methods: Twenty rats with regular 4-days oestrous cycle divided into 4 groups (N=5) were used. Group I received quinine at 30 
mg/kg body weight by gavage for 28 days after which they were sacrificed. The ovaries were excised for biochemical oxidation 
of  glutathione peroxidase (GSH), superoxide dismutase (SOD), catalase and malondialdehyde (MDA). Group II received single 
dose quinine at 30 mg/kg body weight at 0900 hrs on day of  proestrus. Blood was obtained at 1800 hrs for hormonal assay of  
FSH and LH. The animals were sacrificed the next morning on estrus: oviducts were examined for ova count.  Groups III and 
IV served as controls.
Results: Quinine treated rats recorded zero number of  ova compared to control. Serum concentration of  LH reduced signifi-
cantly in the quinine treated group compared to the control.  Furthermore, quinine significantly decreased the oxidant status of  
GSH, SOD and catalase and significantly increased MDA levels in the ovary compared to the control group.
Conclusion: Quinine completely blocks ovulation, suppresses LH surge, and produces oxidative stress in the ovary.
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Introduction
Quinine is a cinchona alkaloid that belongs to the aryl 
amino alcohol group of  drugs. Almost 400 years after 
Jesuit priests first documented its efficacy; quinine still 
remains a therapeutic anti-malarial drug as seen on the 
WHO Model List of  Essential Medicines1.  Quinine is 
still a potent drug in the treatment of  the four species of  
malaria parasites, and is still the treatment of  choice for 
cerebral malaria2 and nocturnal leg cramp3.
Increased production of  reactive oxygen species (ROS) in 
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the whole blood has been observed in patients with acute 
falciparum malaria4 and also in P. vinckei infected mice5. The 
administration of  quinine to non-malarious individuals 
elicited a flux in erythrocyte lipid peroxidation; with an 
initial increase followed by a reduction in lipid peroxida-
tion6. Quinine has been reported to generate ROS when 
photosensitized in the presence of  UV-B radiation even 
within a cellular environment7.
Most of  the in-vivo and in-vitro studies to determine the 
effect of  quinine on the reproductive system and func-
tion have been carried out on males. The reports from 
some of  these studies using animal models have shown 
that quinine possesses anti-spermatogenic activities: dis-
rupts spermatogenesis, reduces sperm motility, morphol-
ogy and sperm count and is deleterious to testicular his-
toarchitecture8-10.
There is a dearth of  literature on the effect of  quinine on 
the female reproductive system. This study was carried 
out to determine the effect of  quinine on ovarian func-




A total of  thirty regular 4-day cycling female rats of  
Sprague-Dawley strain weighing between 120 – 200 g 
were used. The animals had access to food and water ad 
libitum. They were maintained at 25 ± 3°C with photo-
periodicity of  12: 12 light: darkness. The animals were 
observed for clinical signs of  drug toxicity throughout 
the duration of  the experiment. All procedures involving 
animals in this study were approved by the Departmen-
tal Committee on the use and care of  animals and tissue 
collection.
Quinine
Quinine dihydrochloride injection, a product of  Jiangsu, 
China, was given intramuscularly at a single dose of  30 
mg/kg/day on the morning of  proestrus to determine 
ovulation. To determine oxidative stress, quinine sulphate 
tablet a product of  Wockhart was constituted into a solu-
tion by the addition of  distilled water and administered 
at the same dose orally by gavage once daily for 28 days. 
Our choice of  dosage selection was based on a previous 
study8. This dose falls within the no-effect level and is 
therefore grossly non-toxic11. Control animals received 1 
ml of  distilled water. 
Determination of  ovulation
Ovulation studies were determined using the method of  
Kim et al12. Briefly, vaginal smear was taken daily to de-
termine the stage of  the oestrous cycle. Rats with a pre-
ponderance of  uniformly nucleated cells indicating the 
proestrus phase, received a single dose of  quinine intra-
muscularly at 9 a.m. Later the same day in the evening at 6 
p.m, blood was collected via ocular puncture using a cap-
illary tube and was stored in heparinized bottles. The next 
day, which was the day of  estrus, the rats were sacrificed 
by cervical dislocation at 10 a.m. A ventral laparotomy 
was performed and the oviduct was excised, placed on 
glass slides with a drop of  saline and covered with cover 
slips. It was squeezed with both sides being gently rocked. 
Any ovum found in the distended ampulla was counted 
under a light microscope.
Hormonal assay
Blood was centrifuged and serum was decanted from the 
plasma and assayed in batches with control sera at both 
physiological and pathological levels with a microwell kit 
to determine FSH and LH concentrations.
Oxidative stress study
Quinine was administered daily for 28 days by gavage13. 
At the end of  the treatment period, the rats were sacri-
ficed by cervical dislocation. A ventral laparotomy was 
performed and the ovaries were excised and kept frozen 
at -20oC until the day of  assay for biochemical analysis of  
oxidative stress.
 
Preparation of  ovarian tissues for oxidative stress
The ovarian tissue was homogenized in a Teflon-glass-
homogenizer with a buffer containing 1.5% potassium 
chloride to obtain 1:10 (w/v) whole homogenate. MDA 
was measured using the method described by Farombi 
et al14. The GSH level in ovarian tissue was estimated as 
described by Rukkumani et al15. Catalase was assayed col-
orimetrically at 620 nm and expressed as _mol of  H2O2 
consumed/min as described by Rukkumani et al15. Total 
SOD activity was measured by the method described by 
Sun et al16.
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Statistical analysis
Results were analyzed and expressed as mean ± standard 
error of  mean (Mean ± SEM) and subjected to statistical 
analysis using paired sample t-test. Statistical significance 
was considered at p< 0.05.
Results
Effect on body weight and ovulation
Control rats gained weight in the course of  the treatment 
and the gain in weight was significantly different at the 
end of  the study.  On the other hand the weight of  the 
quinine treated rats reduced significantly by the end of  
the treatment (Table 1).  
In addition, quinine completely blocked ovulation as no 
ovum was observed in the oviduct in the morning of  es-
trus. However, control animals recorded a count of  7.6 ± 
0.5 numbers of  ova.
Effect on serum concentrations of  FSH and LH
Serum concentrations of  both FSH and LH (p<0.05) de-
creased when treated group was compared to the control 
values (Table 2).
Table 2: Effect of administration of quinine on serum levels of FSH and LH  in cyclic Sprague-Dawley rats. 
 
Treatment groups                                 FSH (µlU/ml)                              LH (µlU/ml) 
Control                                                   0.47 ± 0.07                                   1.17 ± 0.13 
Quinine                                                  0.38 ± 0.07                                   0.81 ± 0.05* 
                                       Values are expressed as mean ± S.E.M (N=5). *p<0.05 vs. control. 
Effect on markers of  oxidative stress
The study showed that MDA increased significantly while 
GSH, Catalase and SOD activities reduced significantly 
when compared to the control group (Table 3).
Table 3: Effect of administration of quinine on biochemical oxidation of MDA, GSH, catalase and SOD in cyclic Sprague-Dawley rats. 
 





    
MDA                     GSH                       CATALASE                SOD                                       (µmol/ml/mg)      (µmol/ml/mg)         
(µmole/ml/min/      (µmole/ml/min/mg 
                                                                 mg pro)                          pro)                          
  
Control                 2.63 ± 0.07          30.06 ± 0.40           12.78 ± 0.17                2.38 ± 0.35 
Quinine                 4.39 ± 0.04*        18.39 ± 0.53*         10.44 ± 0.53*              2.09 ± 0.08* 
           Values are expressed as mean ± S.E.M (N=5). *p<0.05 vs. control. 
Table 1: Effect of administration of quinine on body weight and on ovulation in cyclic Sprague-Dawley rats. 
 
Treatment groups                                 Before (g)                                    After (g) 
Control                                                  162.4 ± 5.2                                   187 ± 4.6 
Quinine                                                  185.2 ± 4.0                                   157.8 ± 6.8* 
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MDA        GSH CATALASE                SOD                                       (µmol/ml/mg)      (µmol/ml/mg)         
(µmole/ml/min/      (µmole/ml/min/mg
                                                                 mg pro)                          pro)                          
  
Control                 2.63 ± 0.07          30.06 ± 0.40           12.78 ± 0.17                2.38 ± 0.35 
Quinine                 4.39 ± 0.04*        18.39 ± 0.53*         10.44 ± 0.53*              2.09 ± 0.08* 
           Values are expressed as mean ± S.E.M (N=5). *p<0.05 vs. control. 
Treatment groups       Before (g)                      After (g)         No. of ova shed in the oviduct 
Control                      162.4 ± 5.2                      187 ± 4.6             7.6 ± 0.5 
Quinine          185.2 ± 4.0              157.8 ± 6.8*  0.0 ± 0.0* 
 
Table 1: Effect of administration of quinine o  body weight and on ovulation in cyclic Sprague-Dawley rats. 
 
Treatment groups                                 Before (g)                                    After (g) 
Control                                                  162.4 ± 5.2                                   187 ± 4.6 
Quinine                                                  185.2 ± 4.0                                   157.8 ± 6. * 
                                       Values are expressed as mean ± S.E.M (N=5). *p<0.05 vs. control. 
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Discussion
Body weight decreased significantly in the quinine treated 
rats compared to the control rats in this study. This re-
sult is consistent with another study in which mice were 
fed quinine diet. The authors suggested that quinine diet 
caused weight loss in the mice as a result of  de-regula-
tion in intestinal nutrient absorption rather than energy 
expenditure17. 
Numerous animal and human studies have demonstrat-
ed the presence of  ROS in the female reproductive tract 
such as in the ovaries18-20, the fallopian tubes21 and in em-
bryos22. ROS is involved in the modulation of  an entire 
spectrum of  physiological reproductive functions such as 
oocyte maturation, ovarian steroidogenesis, corpus lute-
al function and luteolysis18-20,23. In the reproductive tract, 
increased ROS generation is limited by a variety of  an-
ti-oxidant enzymes, such as SOD, catalase, and various 
peroxidases. A delicate balance exists between ROS and 
anti-oxidant enzymes in the ovaries.  Anti-oxidant en-
zymes neutralize ROS production and protect the oocyte 
and embryo from apoptosis resulting from nucleic acid 
strand breaks, lipid peroxidation, protein degradation and 
ultimately, cell death24. SOD causes a dismutation of  su-
peroxide radicals to H2O2, which is further detoxified to 
water and oxygen by catalase or GSH. 
Results from this study revealed that administration of  
quinine significantly elevated the level of  MDA, and at 
the same time significantly reduced the levels of  GSH, 
SOD and Catalase in the rat ovaries when compared to 
the control. The report of  this study is in agreement with 
Osinubi et al.,25 who reported that quinine significantly 
increased levels of  MDA in the testes. Also, in anoth-
er study using amodiaquine, it was reported that amo-
diaquine caused a significant reduction in the enzymatic 
anti-oxidant activities of  SOD and catalase in the ovaries 
of  Sprague-Dawley rats13. An imbalance between ROS 
production and anti-oxidants results in oxidative stress. 
From the result of  this study, it can be deduced therefore 
that the ovaries were under oxidative stress.
Certain drugs acting at various levels of  the hypothalam-
ic-pituitary-ovarian axis have been reported to impair 
ovulation and ultimately, fertility26. Ovulation is the ac-
complishment of  a series of  events orchestrated by the 
surge of  LH. These events are characterized by resump-
tion of  meiosis, break down of  germinal vesicle, gran-
ulosa luteinization, stigma formation and ultimately the 
release of  a mature ovum27. In this study, the administra-
tion of  quinine at 0900 hrs on the morning of  proestrus 
blocked ovulation completely as not a single ovum was 
found in the oviduct compared to the control. The result 
of  this study is in concert with other investigators who 
reported a complete block in ovulation with regression of  
LH surge when chloroquine was administered between 
0900 and 1000 hrs on proestrus28,29. No significant differ-
ence was observed in the serum concentration of  FSH 
however LH levels decreased significantly from control 
values. It is a well-established fact that on the afternoon 
of  proestrus, about 2 to 3 p.m., the circulating levels of  
LH begins to increase rapidly and ultimately reach peak 
levels by 5 to 7 p.m. on that same evening. This proestrus 
surge of  LH is responsible for the process of  and events 
following ovulation. This surge of  LH actuates follicular 
rupture and the resultant ovulation on the morning of  
estrus30. The significantly reduced levels of  LH observed 
in this study revealed that the expected surge in LH that 
induces follicular rupture and eventual ovulation was sup-
pressed. 
As shown in our study above, quinine produces overpro-
duction of  ROS a fact suggested by the significantly in-
creased levels of  MDA an important lipid peroxidation 
marker. ROS represents the most important class of  free 
radicals generated in living systems. ROS is generated 
in the form of  hydrogen peroxide (H2O2), superoxide 
radical (O2•−), and hydroxyl radical (OH•).  H2O2 is a 
weak oxidizing agent that can cross rapidly inside the cell 
membranes and damage intracellular systems31. Removal 
and neutralization of  H2O2 by catalase and glutathione 
peroxidase is very important for the protection of  liv-
ing systems. Hydrogen peroxide is constantly produced 
in cells and has been implicated in several ovulation-re-
lated events such as steroid hormone production32,33. It 
has been shown that the addition of  hydrogen peroxide 
to a culture of  human chorionic gonadotropin-stimulated 
luteal cells resulted in reduction of  both progesterone 
and estradiol production20. Estrogens and progesterone 
are important in the normal functioning of  the female 
reproductive system. The balance in hormonal interplay 
between estrogens and progesterone is responsible for 
a normal regular cycle34,35. Several authors have demon-
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strated that progesterone secreted during the diestrus 
phase intensifies the negative feedback of  estradiol on 
basal LH secretion and when the level of  progesterone 
falls at luteal regression, estradiol and LH levels rise and 
ovulation occurs within the following 6- 8 h36-39. Also, low 
levels of  estrogen inhibit ovulation by delaying the estro-
gen triggering of  LH surge.
Although, progesterone and estrogen levels were not de-
termined in this study however, it may be inferred that 
the oxidative stress produced by the administration of  
quinine may have suppressed the production of  proges-
terone and estrogen. The suppressed levels of  proges-
terone and estrogen may have inhibited the threshold of  
the neural and/or hypophyseal mechanisms responsible 
for ovulatory LH release leading to a complete block in 
ovulation in the morning of  estrus. Although the dose 
given in this study falls below the recommended thera-
peutic dose in humans6,40 however, it is too early to begin 
to extrapolate the findings of  this study to humans. Fur-
ther studies should be carried out to elucidate the exact 
mechanism of  action by which quinine blocks ovulation 
and induces oxidative stress in rats. Howbeit, quinine 
should be taken with caution in women who are under-
going treatment for infertility.
Conclusion
The study demonstrated that quinine suppressed LH 
surge, completely blocked ovulation and produced oxida-
tive stress in Sprague-Dawley rats.
 
Recommendation
We have attempted to demonstrate an oxidative stress 
pathway by which quinine blocks ovulation however; 
our study was limited because we failed to determine the 
levels of  progesterone and estrogen. Further studies to 
determine progesterone and estrogen levels should be 
carried out in order to substantiate and or validate our 
findings.
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